(MedPage Today) — Low-dose treatment with lysergic acid diethylamide (LSD) failed to improve symptoms of attention deficit-hyperactivity disorder (ADHD) in adults, a double-blind randomized phase IIa trial showed.
After 6 weeks, the group who…
Source link : https://www.medpagetoday.com/psychiatry/adhd-add/114735
Author :
Publish date : 2025-03-19 19:28:00
Copyright for syndicated content belongs to the linked Source.
